AI Verdict
HIMS has stronger fundamentals based on our AI analysis.
HIPOW vs HIMS Fundamental Comparison
| Metric | HIPOW | HIMS |
|---|---|---|
| Revenue | $468.6M | $2.3B |
| Net Income | $57.7M | $128.4M |
| Net Margin | 12.3% | 5.5% |
| ROE | 13.2% | 23.7% |
| ROA | 3.0% | 6.0% |
| Current Ratio | 0.69x | 1.90x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | $2.22 | $0.51 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
HIPOW vs HIMS: Frequently Asked Questions
Is HIPOW or HIMS a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), HIMS has stronger fundamentals. HIPOW is rated HOLD (48% confidence) while HIMS is rated BUY (72% confidence). This is not investment advice.
How does HIPOW compare to HIMS fundamentally?
Hippo Holdings Inc. has ROE of 13.2% vs Hims & Hers Health, Inc.'s 23.7%. Net margins are 12.3% vs 5.5% respectively.
Which stock pays higher dividends, HIPOW or HIMS?
HIPOW has a dividend yield of N/A or no dividend while HIMS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in HIPOW or HIMS for long term?
For long-term investing, consider that HIPOW has HOLD rating with 48% confidence, while HIMS has BUY rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about HIPOW vs HIMS?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For HIPOW vs HIMS, the AI consensus favors HIMS based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.